KELLY CLEAVES: Open Payments
NPI 1710245949 · HILLSBORO, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$518 in 36 payments from 8 companies in 2025. Trend: 2023 $168 · 2024 $76 · 2025 $518
Food & beverage: $518
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $186 |
| E.R. Squibb & Sons, L.L.C. | 5 | $133 |
| Bausch Health US, LLC | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| Alkermes, Inc. | 1 | $30 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
Products named: VRAYLAR, COBENFY, APLENZIN, REXULTI, TRINTELLIX, LYBALVI, Jornay PM, SPRAVATO.
Industry payments across OR — which companies pay providers there.
